Literature DB >> 9381445

[A letter to benzodiazepine users--an efficient way to reduce the prescription].

G Mouland1.   

Abstract

Eight general practitioners in Aust-Agder county (southern Norway) had 169 patients who were found to be suitable for receiving a letter arguing for reduction of daily benzodiazepine intake, or cessation of the drug. The patients were randomly allocated to an intervention or control group. 4-12 months after receiving the letter, the amount of benzodiazepines (DDD/six months) prescribed had decreased by 51% in the intervention group and by 24% in the control group. The impression of the participating doctors was that the patients appreciated the information and that it was easier than expected to get the patients to reduce benzodiazepine intake. The marked reduction in the control group too indicates that the doctors' active attitude towards dose reduction had been applied towards these patients as well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9381445

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  4 in total

1.  Evaluation of two strategies to implement physical cancer rehabilitation guidelines for survivors of abdominopelvic cavity tumors: a controlled before-and-after study.

Authors:  Charlotte IJsbrandy; Petronella B Ottevanger; Winald R Gerritsen; Wim H van Harten; Rosella P M G Hermens
Journal:  J Cancer Surviv       Date:  2021-09-14       Impact factor: 4.062

2.  An approach to reduce benzodiazepine and cyclopyrrolone use in general practice : a study based on a Danish population.

Authors:  Viggo R K Jørgensen
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  Patient-mediated interventions to improve professional practice.

Authors:  Marita S Fønhus; Therese K Dalsbø; Marit Johansen; Atle Fretheim; Helge Skirbekk; Signe A Flottorp
Journal:  Cochrane Database Syst Rev       Date:  2018-09-11

4.  Reduction in the use of benzodiazepines and cyclopyrrolones in general practice.

Authors:  Viggo K Jørgensen; Birgit S Toft
Journal:  Pharm Pract (Granada)       Date:  2008-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.